There are signs that the next-generation sequencing (NGS) field is about to get a little more crowded—and a lot more interesting. La Jolla-based Singular Genomics Systems says its recently launched G4 ...
The FDA issued a letter noting that nearly the entire Illumina Inc's (NASDAQ: ILMN) sequencer lineup carries a cybersecurity vulnerability that could impact genomic data results or even result in a ...
Illumina, Inc. ILMN recently reached a major milestone by surpassing over 200 orders for its revolutionary NovaSeq X sequencing system in the first quarter of 2023. Strong customer demand drives ...
Illumina operates in the genetic and genomic analysis sector, providing products and services for research and clinical environments. The company's strategic priorities include achieving top-line ...
Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Next Generation Sequencing Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. This ...
Illumina, Inc. ILMN has been gaining from sequential segmental growth. The company’s focus on partnerships and greater market adoption of its products is expected to contribute further. However, stiff ...
The NextSeq 2000 Systems are designed to support emerging and mid-throughput sequencing applications, accommodating a diverse range of methods such as exome sequencing, target enrichment, single-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback